Systemic absorption and pharmacokinetics of single-dose early intravesical mitomycin c after transurethral resection of non-muscle-invasive bladder cancer

Urology

Volumn 82, Issue 2, 2013, Pages 400-404

  Maffezzini, Massimo ^a   Campodonico, Fabio ^a   Manuputty, Egi E ^b   Puntoni, Matteo ^a   Martelli, Antonietta ^c   Marini, Valeria ^c   Tamagno, Stefania ^a   Mattioli, Francesca ^c  

^a GALLIERA HOSPITAL   (Italy)

^b Cikini Communion of Churces in Indonesia Hospital   (Indonesia)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DYSURIA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; NON MUSCLE INVASIVE BLADDER CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRANSURETHRAL RESECTION;

ABSORPTION; AGED; ANTIBIOTICS, ANTINEOPLASTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; SEX FACTORS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84880919223     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.03.036     Document Type: Article

References (13)

1. M.E. Nielsen, A.B. Smith, and R.S. Pruthi Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey BJU Int 110 2012 967 972
2. M. Babjuk, W. Oosterlink, and R.J. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
3. Hall MG, Chang SS, Dalbagni G et al. Guideline for the management of non muscle invasive bladder cancer: (stages Ta, T1, and Tis): 2007 update. American Urological Association Education and Research, Inc., 2007. Available at http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines. cfm?sub=bc. Accessed December 28, 2012.
4. K. Jauhiainen, S. Eksborg, and L. Kangas The absorption of doxorubicin and mitomycin C in perioperative instillation. An experimental and clinical study Eur Urol 11 1985 269 272
5. Z. Wajsman, R.A. Dhafir, and M. Pfeffer Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors J Urol 132 1984 30 33
6. M. Maffezzini, F. Campodonico, and M. Puntoni Systemic absorption and pharmacokinetics of single-dose intravesical gemcitabine after transurethral resection of the bladder in non-muscle-invasive bladder cancer Urology 74 2009 1078 1084
7. R. Paroni, C. Arcelloni, and De Vecchi Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction Clin Chem 43 1997 615 618
8. National Cancer Institute. Cancer Therapy Evaluation Program. Protocol development, Available at http://ctep.cancer.gov/protocolDevelopment/electronic- applications/ctc.htm. Accessed December 28, 2012.
9. M.G. Kenward, and J.H. Roger Small sample inference for fixed effects from restricted maximum likelihood Biometrics 53 1997 983 997
10. Y. Benjamini, and Y. Hochberg Controlling the false discovery rates: a practical and powerful approach to multiple testing J Roy Stat Soc B 35 1995 289 300
11. M. Brausi Challenging the EAU guidelines on non-muscle-invasive bladder cancer (NMIBC): single instillation of chemotherapy after transurethral resection of NMIBC and chemotherapy versus bacillus Calmette-Guérin in treatment of intermediate-risk tumours Eur Urol Suppl 9 2010 406 410
12. R.J. Sylvester, W. Oosterlink, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrences in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190
13. J.T. Dalton, G. Wientjes, and R.A. Badalament Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer Cancer Res 51 1991 5144 5152